Cargando…
Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19
The coronavirus disease 2019 (COVID-19), is a highly contagious transmittable disease caused by a recently discovered coronavirus, pathogenic SARS-CoV-2. Followed by the emergence of highly pathogenic coronaviruses in 2003 SARS-CoV, in 2012 MERS-CoV, now in 2019 pathogenic SARS-CoV-2, is associated...
Autores principales: | Chatterjee, Swapan K., Saha, Snigdha, Munoz, Maria Nilda M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431665/ https://www.ncbi.nlm.nih.gov/pubmed/32850977 http://dx.doi.org/10.3389/fmolb.2020.00196 |
Ejemplares similares
-
Molecular and Clinical Investigation of COVID-19: From Pathogenesis and Immune Responses to Novel Diagnosis and Treatment
por: Kashani, Narjes Riahi, et al.
Publicado: (2022) -
Therapeutic Strategies in the Management of COVID-19
por: Naik, Rajashri R., et al.
Publicado: (2021) -
Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
por: Kenny, Grace, et al.
Publicado: (2023) -
Whole-Slide Image Analysis of Human Pancreas Samples to Elucidate the Immunopathogenesis of Type 1 Diabetes Using the QuPath Software
por: Apaolaza, Paola S., et al.
Publicado: (2021) -
Editorial: Targeting glioblastoma: Mechanisms of pathology and novel therapeutic strategies
por: Kusaczuk, Magdalena, et al.
Publicado: (2023)